NIH Guide: Weekly Index | grants.nih.gov

An official website of the United States government

Here's how you know

U.S. Department of Health and Human Services National Institutes of Health

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Weekly NIH Funding Opportunities and Notices

February 24, 2023

Policy Notices

Updated Process for Requesting Drawdowns Outside of the Liquidation Period
(NOT-OD-23-086)

National Institutes of Health

General Notices

Request for Information on the NIH Plan to Enhance Public Access to the Results of NIH-Supported Research
(NOT-OD-23-091)

Office of the Director, NIH

Notice of Changes to Funding Opportunities

Notice of Early Expiration of Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine" NOT-AI-23-007
(NOT-AI-23-030)

National Institute of Allergy and Infectious Diseases
Notice of NIGMS Withdrawal of Participation from PA-22-177 "PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
(NOT-GM-23-032)

National Institute of General Medical Sciences
Notice of NIGMS Withdrawal of Participation from PA-22-179 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
(NOT-GM-23-033)

National Institute of General Medical Sciences
Notice of Participation of the National Human Genome Research Institute (NHGRI) in PA-20-163: Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)
(NOT-HG-23-021)

National Human Genome Research Institute
Notice of Participation of NIMH in PAR-20-315, "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)"
(NOT-MH-23-220)

National Institute of Mental Health
Notice of NIMH Withdrawal from Participation in PAR-23-030 "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)"
(NOT-MH-23-225)

National Institute of Mental Health
Notice of Clarification Regarding Eligibility Information for SBIR/STTR Commercialization Readiness Pilot Program (CRP)
(NOT-OD-23-087)

Office of the Director, NIH
Notice of Change to Minimum Performance Standards for SBIR and STTR Applicants
(NOT-OD-23-092)

National Institutes of Health

Notices of Intent to Publish

Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
(NOT-NS-23-068)

National Institute of Neurological Disorders and Stroke

National Institute on Aging

National Institute of Mental Health
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
(NOT-NS-23-069)

National Institute of Neurological Disorders and Stroke

National Institute on Aging

National Institute of Mental Health

Requests for Proposal

Pre-Solicitation Notice: Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA), RFP: 75N93022R00017
(NOT-AI-23-034)

National Institute of Allergy and Infectious Diseases

Notices of Special Interest

Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine
(NOT-AI-23-031)

National Institute of Allergy and Infectious Diseases
Notice of Special Interest (NOSI): Administrative Supplement to Support Health Policy Research in Cancer Prevention and Control
(NOT-CA-23-044)

National Cancer Institute
Notice of Special Interest (NOSI): Administrative supplements to conduct systematic evidence reviews on the clinical utility of cancer-site specific polygenic risk scores (PRS) for cancer risk assessment
(NOT-CA-23-046)

National Cancer Institute
Notice of Special Interest (NOSI) in Applications to Support Training, Workforce Development, and Diversity Conferences (R13)
(NOT-GM-23-028)

National Institute of General Medical Sciences
Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy
(NOT-HL-23-080)

National Heart, Lung, and Blood Institute
Notice of Special Interest (NOSI): Research supplements to promote workforce diversity and enhance utility and use of Common Fund datasets
(NOT-RM-23-005)

Office of Strategic Coordination (Common Fund)

National Human Genome Research Institute

Funding Opportunities

Genomics Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)
(RFA-AI-23-015)

National Institute of Allergy and Infectious Diseases

Application Receipt Date(s): June 2, 2023
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 Clinical Trials Not Allowed)
(RFA-DA-24-008)

National Institute on Drug Abuse

National Library of Medicine

Application Receipt Date(s): August 10, 2023
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed)
(RFA-DA-24-009)

National Institute on Drug Abuse

National Library of Medicine

Application Receipt Date(s): August 10, 2023
Natural History and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional
(RFA-FD-23-028)

Food and Drug Administration

Application Receipt Date(s): May 4, 2023
NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60)
(RFA-OH-23-005)

National Institute for Occupational Safety and Health

Application Receipt Date(s): September 29, 2024

Technical Issues: E-mail OER Webmaster